Salmon calcitonin in the treatment of postmenopausal osteoporosis

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.

Original languageEnglish (US)
Pages (from-to)923-925
Number of pages3
JournalAnnals of internal medicine
Volume107
Issue number6
DOIs
StatePublished - Jan 1 1987

Fingerprint

salmon calcitonin
Postmenopausal Osteoporosis
Bone Resorption
Bone Density
Calcium
Bone and Bones
Injections
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Salmon calcitonin in the treatment of postmenopausal osteoporosis. / Fatourechi, Vahab; Heath, H.

In: Annals of internal medicine, Vol. 107, No. 6, 01.01.1987, p. 923-925.

Research output: Contribution to journalReview article

@article{e4f6ee80aa7e4fd7bdc95a3b14c399b5,
title = "Salmon calcitonin in the treatment of postmenopausal osteoporosis",
abstract = "In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.",
author = "Vahab Fatourechi and H. Heath",
year = "1987",
month = "1",
day = "1",
doi = "10.7326/0003-4819-107-6-923",
language = "English (US)",
volume = "107",
pages = "923--925",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

TY - JOUR

T1 - Salmon calcitonin in the treatment of postmenopausal osteoporosis

AU - Fatourechi, Vahab

AU - Heath, H.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.

AB - In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.

UR - http://www.scopus.com/inward/record.url?scp=0023555301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023555301&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-107-6-923

DO - 10.7326/0003-4819-107-6-923

M3 - Review article

C2 - 3318613

AN - SCOPUS:0023555301

VL - 107

SP - 923

EP - 925

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -